All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

NIH unveils plan to centralize grant reviews in effort to save $65M-plus annually

NIH unveils plan to centralize grant reviews in effort ...

Mar 10, 2025  0

Harbour BioMed launches new obesity biotech on mission to preserve muscle mass

Harbour BioMed launches new obesity biotech on mission ...

Mar 12, 2025  0

Pfizer builds out oncology team with appointment of Novartis vet Jeff Legos

Pfizer builds out oncology team with appointment of Nov...

Feb 9, 2025  0